23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV

第23届艾滋病毒合并症和药物不良反应年度国际研讨会

• 批准号: 10327072
• 负责人: TODD T BROWN
• 金额: $ 4.3万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-07-20 至 2022-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10327072
• 关键词: Acquired Immunodeficiency Syndrome; Adolescent; Adverse effects; Age; Area; COVID-19; COVID-19 pandemic; Cardiovascular Diseases; Cause of Death; Child; Chronic; Chronic Disease; Clinical; Clinical Management; Collaborations; Communicable Diseases; Communities; Disease; Educational workshop; Elements; England; Etiology; Europe; European; Event; Feedback; Fostering; Goals; HIV; Home; Inflammation; International; International AIDS; Liver diseases; London; Longevity; Opportunistic Infections; Oral; Pathogenesis; Persons; Play; Program Development; Psychiatrist; Research; Research Personnel; Retroviridae Infections; Risk Factors; Role; Schedule; Scholarship; Societies; South Africa; Specialist; Stroke; Training Programs; Translational Research; Travel; Ursidae Family; Work; adverse drug reaction; antiretroviral therapy; career; career development; clinical practice; co-infection; comorbidity; disability; healthspan; improved; low and middle-income countries; meetings; non-alcoholic fatty liver disease; pediatric cardiologist; peer; posters; programs; research clinical testing; success; symposium; virtual; Acquired Immunodeficiency Syndrome; Adolescent; Adverse effects; Age; Area; COVID-19; COVID-19 pandemic; Cardiovascular Diseases; Cause of Death; Child; Chronic; Chronic Disease; Clinical; Clinical Management; Collaborations; Communicable Diseases; Communities; Disease; Educational workshop; Elements; England; Etiology; Europe; European; Event; Feedback; Fostering; Goals; HIV; Home; Inflammation; International; International AIDS; Liver diseases; London; Longevity; Opportunistic Infections; Oral; Pathogenesis; Persons; Play; Program Development; Psychiatrist; Research; Research Personnel; Retroviridae Infections; Risk Factors; Role; Schedule; Scholarship; Societies; South Africa; Specialist; Stroke; Training Programs; Translational Research; Travel; Ursidae Family; Work; adverse drug reaction; antiretroviral therapy; career; career development; clinical practice; co-infection; comorbidity; disability; healthspan; improved; low and middle-income countries; meetings; non-alcoholic fatty liver disease; pediatric cardiologist; peer; posters; programs; research clinical testing; success; symposium; virtual

With the success of antiretroviral therapy (ART), comorbid diseases are now the leading causes of death and disability in people living with HIV around the globe, including low and middle income countries (LMIC). Large meetings, such as the Conference for Retroviruses and Opportunistic Infections and the International AIDS Society Conference, are important venues for scientific exchange regarding the latest advances in HIV Comorbidity research, but smaller, more intimate formats,that emphasize discussion and networking are critical to the career development of HIV Comorbidity investigators. The International Workshop for Comorbidities and Adverse Drug Reactions in HIV, now in its 23rd year, provides <200 delegates with an opportunity to come together to discuss the latest findings and controversies in HIV Comorbidity research in one-room, two-day format. Plenary speakers are either noted experts from outside of HIV research or HIV researchers with expertise in a specific comorbidity. Abstract presentations including 24 15- minute talks and a poster session provide ample opportunity for researchers to present and get feedback on their latest work. With this R13, we propose to enhance the 23rd Workshop (October 25th/26th in London) with the following aims: 1) to provide a forum for the latest HIV Comorbidity research in LMIC by offering travel scholarships to LMIC investigators, supporting an internationally-recognized expert in non-communicable diseases in LMIC as a plenary speaker, and liaising with international training programs, 2) to support early-stage investigators with a scholarship program and a Career Development Studio, and guided poster tour, 3) to increase the impact of the Workshop through the webcast of plenary and abstract presentations. By providing a “scientific home” to an increasing number of HIV Comorbidity investigators from around the world, we hope to catalyze future research efforts in HIV Comorbidities and facilitate the translation of research findings into clinical strategies that can improve the lifespan and healthspan of PLWH.

随着抗逆转录病毒疗法（ART）的成功，合并症现在是主要原因 全球艾滋病毒感染者的死亡和残疾，包括低收入和中等收入 国家（LMIC）。大型会议，例如逆转录病毒和机会主义会议 感染和国际艾滋病协会会议是科学的重要场所 有关HIV合并症研究最新进展的交流，但更较小，更亲密 格式，强调讨论和网络对艾滋病毒的职业发展至关重要 合并症调查员。合并症和不良药物的国际研讨会 艾滋病毒的反应（现在已有23年了）为200名代表提供了机会 共同讨论一室艾滋病毒合并症研究的最新发现和争议， 两天格式。全体演讲者要么是来自艾滋病毒研究以外的专家或艾滋病毒 具有特定合并症专业知识的研究人员。摘要演示文稿，包括24个15- 分钟会谈和海报会议为研究人员提供了充足的机会，可以展示和获取 他们最新工作的反馈。使用此R13，我们建议增强第23届研讨会（10月 伦敦25日/26日）以下目的：1）为最新的HIV合并症提供论坛 通过向LMIC调查人员提供旅行奖学金，在LMIC中进行研究 国际公认的LMIC非通信疾病专家作为全体发言人， 并通过国际培训计划联络，2）支持早期调查员 奖学金计划和职业发展工作室，以及指导海报之旅，3）增加 研讨会通过全体会议和抽象演示的网络广播的影响。经过 为越来越多的HIV合并症调查人员提供了“科学家” 在世界各地，我们希望催化未来的HIV合并症研究工作，并促进 将研究结果转化为临床策略，可以改善寿命和 PLWH的HealthSpan。